V. Raman Muthusamy
University of California, Los Angeles
Appearances
DateMay 8, 2023This session will highlight the current state of the art around innovation in endoscopy as it pertains to climate, the environment, and the endoscopist…Presenter
University of California, Los Angeles- DateMay 8, 2023This session will highlight the current state of the art around innovation in endoscopy as it pertains to climate, the environment, and the endoscopist…
Presenters
University of California, Los AngelesMayo Clinic 
DateMay 6, 2023Handout [https://ddw.digitellinc…Presenters
Oregon Health & Science UniversityUniversity of California, Los AngelesUniversity of Michigan- DateMay 7, 2023Ampullary neoplasia (AN) is a rare disease, but its incidence is increasing…
Presenter
Speakers
UCLAUniversity of California, Los Angeles - DateMay 6, 2023Background: GI endoscopy procedures are critical for the screening, diagnosis, and treatment of a variety of patient signs/symptoms…
Presenter
University of California, Los Angeles - DateMay 6, 2023BACKGROUND AND AIM: Despite extensive cleaning and disinfection protocols, 5-15% of ready-to-use duodenoscopes are still contaminated with high concern (HC) microorganisms such as _Klebsiella pneumoniae_, _Escherichia coli_ and _Pseudomonas aeruginosa_…
Presenter
Speakers
University of California, Los AngelesUniversity of California Los Angeles; Veterans Affairs - DateMay 7, 2023A case-based panel discussion regarding integrating new technology in the management of non-dysplastic Barrett's esophagus patients…
Presenter
Speakers
University of California, Los Angeles - DateMay 20, 2024INTRODUCTION: Post-polypectomy surveillance aims to increase early detection and prevention of colorectal cancer (CRC)…
Presenter
Speakers
University of California, Los AngelesUniversity of California Los Angeles; Veterans Affairs - DateMay 18, 2024Esophageal adenocarcinoma (EAC) has had a rising incidence in the US, prompting guidelines for endoscopic screening in those with risk factors for its precursor Barret’s esophagus (BE)…
Presenter
Speakers
University of California, Los AngelesUniversity of Kansas School of Medicine and Kansas City VA Medical CenterWashington University School of MedicineWashington University in St. LouisUniversity of Colorado School of MedicineUniversity of ColoradoUCLANorthwestern University - DateMay 18, 2024Recent studies have described the durability of EET for BE-related neoplasia and the risk of neoplastic recurrence after achieving complete eradication of intestinal metaplasia (CE-IM). Current guidelines for endoscopic surveillance intervals post-EET are based on limited evidence…
Presenter
Johns Hopkins HospitalSpeakers
Washington University in St. LouisUniversity of Colorado School of MedicineUniversity of North Carolina at Chapel Hill School of MedicineMayo ClinicNorthwestern UniversityWashington University School of MedicineUniversity of California, Los AngelesUniversity of North CarolinaUCLAUniversity of Colorado - DateMay 19, 2024INTRODUCTION: EET is endorsed by guidelines for treatment of BE-related neoplasia patients. Few studies describe long-term durability outcomes in BE patients who achieve complete eradication of intestinal metaplasia (CE-IM) following EET…
Presenter
Speakers
University of California, Los AngelesUCLAUniversity of Kansas School of Medicine and Kansas City VA Medical CenterWashington University School of MedicineWashington University in St. LouisUniversity of Colorado School of MedicineNorthwestern UniversityUniversity of Colorado 
DateMay 5, 2025This session, comprised of the top abstracts submitted to the Pancreatic Disorders (PAN) Section, highlights groundbreaking research in the field of pancreatitis and pancreatic adenocarcinoma…Moderators
University of California, Los AngelesJohns Hopkins University School of Medicine
